202 related articles for article (PubMed ID: 22189171)
1. Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?
Dogru T; Genc H; Tapan S; Ercin CN; Ors F; Aslan F; Kara M; Sertoglu E; Bagci S; Kurt I; Sonmez A
Diabetes Res Clin Pract; 2012 Apr; 96(1):47-52. PubMed ID: 22189171
[TBL] [Abstract][Full Text] [Related]
2. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.
Dogru T; Genc H; Tapan S; Aslan F; Ercin CN; Ors F; Kara M; Sertoglu E; Karslioglu Y; Bagci S; Kurt I; Sonmez A
Clin Endocrinol (Oxf); 2013 May; 78(5):712-7. PubMed ID: 22676641
[TBL] [Abstract][Full Text] [Related]
3. Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology.
Boga S; Alkim H; Koksal AR; Bayram M; Ozguven MB; Ergun M; Neijmann ST; Ozgon G; Alkim C
J Investig Med; 2015 Oct; 63(7):871-7. PubMed ID: 26244718
[TBL] [Abstract][Full Text] [Related]
4. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression.
Bhatia L; Scorletti E; Curzen N; Clough GF; Calder PC; Byrne CD
Atherosclerosis; 2016 Mar; 246():13-20. PubMed ID: 26748347
[TBL] [Abstract][Full Text] [Related]
5. Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.
Yuksel M; Yildiz A; Oylumlu M; Turkcu FM; Bilik MZ; Ekinci A; Elbey B; Tekbas E; Alan S
Clin Rheumatol; 2016 Mar; 35(3):701-8. PubMed ID: 25744156
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease.
Kasumov T; Edmison JM; Dasarathy S; Bennett C; Lopez R; Kalhan SC
Metabolism; 2011 Jun; 60(6):776-81. PubMed ID: 20869086
[TBL] [Abstract][Full Text] [Related]
7. Assessment of endothelial function in patients with nonalcoholic fatty liver disease.
Colak Y; Senates E; Yesil A; Yilmaz Y; Ozturk O; Doganay L; Coskunpinar E; Kahraman OT; Mesci B; Ulasoglu C; Tuncer I
Endocrine; 2013 Feb; 43(1):100-7. PubMed ID: 22661277
[TBL] [Abstract][Full Text] [Related]
8. Carotid intima-media thickness in patients with cardiac syndrome X and its association with high circulating levels of asymmetric dimethylarginine.
Sen N; Poyraz F; Tavil Y; Yazici HU; Turfan M; Hizal F; Topal S; Erdamar H; Cakir E; Yalçin R; Cengel A
Atherosclerosis; 2009 Jun; 204(2):e82-5. PubMed ID: 19010468
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.
Ozturk K; Uygun A; Guler AK; Demirci H; Ozdemir C; Cakir M; Sakin YS; Turker T; Sari S; Demirbas S; Karslıoğlu Y; Saglam M
Atherosclerosis; 2015 Jun; 240(2):380-6. PubMed ID: 25875390
[TBL] [Abstract][Full Text] [Related]
10. Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis.
Başar O; Akbal E; Köklü S; Tuna Y; Koçak E; Başar N; Tok D; Erbiş H; Senes M
Herz; 2013 Jun; 38(4):417-22. PubMed ID: 23324907
[TBL] [Abstract][Full Text] [Related]
11. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
[TBL] [Abstract][Full Text] [Related]
12. Relationship between asymmetric dimethylarginine and asymptomatic carotid atherosclerosis.
Riccioni G; Bucciarelli V; Scotti L; Aceto A; D Orazio N; Di Ilio E; Bucciarelli T
J Biol Regul Homeost Agents; 2010; 24(3):351-8. PubMed ID: 20846483
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease.
Kucukazman M; Ata N; Yavuz B; Dal K; Sen O; Deveci OS; Agladioglu K; Yeniova AO; Nazligul Y; Ertugrul DT
Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):147-51. PubMed ID: 23085576
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and asymmetric dimethylarginine is independently associated with carotid intima media thickness in peritoneal dialysis patients.
Kocak H; Gumuslu S; Ermis C; Mahsereci E; Sahin E; Gocmen AY; Ersoy F; Suleymanlar G; Yakupoglu G; Tuncer M
Am J Nephrol; 2008; 28(1):91-6. PubMed ID: 17914250
[TBL] [Abstract][Full Text] [Related]
15. Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease.
Morisawa T; Nakagomi A; Kohashi K; Kosugi M; Kusama Y; Atarashi H; Shimizu W
Int Heart J; 2015; 56(6):605-12. PubMed ID: 26549398
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance.
Kim SK; Choi YJ; Huh BW; Park SW; Lee EJ; Cho YW; Huh KB
J Clin Endocrinol Metab; 2014 May; 99(5):1879-84. PubMed ID: 24512497
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric dimethylarginine is associated with carotid atherosclerosis in patients with essential hypertension.
Xia W; Xu L; Xu W; Wang X; Yao Y
Clin Exp Hypertens; 2015; 37(5):393-7. PubMed ID: 25496381
[TBL] [Abstract][Full Text] [Related]
18. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
[TBL] [Abstract][Full Text] [Related]
19. Carotid intima-media thickness and plasma asymmetric dimethylarginine in Mexican children exposed to inorganic arsenic.
Osorio-Yáñez C; Ayllon-Vergara JC; Aguilar-Madrid G; Arreola-Mendoza L; Hernández-Castellanos E; Barrera-Hernández A; De Vizcaya-Ruiz A; Del Razo LM
Environ Health Perspect; 2013 Sep; 121(9):1090-6. PubMed ID: 23757599
[TBL] [Abstract][Full Text] [Related]
20. Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study.
Notsu Y; Yano S; Shibata H; Nagai A; Nabika T
Atherosclerosis; 2015 Mar; 239(1):61-6. PubMed ID: 25576847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
